Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase I Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of [GSK461364], a Polo-like Kinase 1 (PLK1) Inhibitor, in Adult Subjects with Advanced Solid Tumor or Non-Hodgkins Lymphoma
GSK461364
PLK107427
NCT00536835
Lymphoma, Non-Hodgkin
Phase 1
 
August 2015

Powered by ideaPoint, Inc.